April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
A comparison of Water Soluble Antioxidants in Human Vitreous Humour in Retinal Ischaemia
Author Affiliations & Notes
  • Louisa Wickham
    Vitreoretinal, Moorfields Eye Hospital, London, United Kingdom
  • Abdul-Kadir Karim
    Anatomy Department, St. Georges University of London, London, United Kingdom
  • Mostafa Elgohary
    Vitreoretinal, Moorfields Eye Hospital, London, United Kingdom
  • Kam Ballagan
    Vitreoretinal, Moorfields Eye Hospital, London, United Kingdom
  • Raymond Moss
    Anatomy Department, St. Georges University of London, London, United Kingdom
  • Maria Firth
    Anatomy Department, St. Georges University of London, London, United Kingdom
  • Gary Firth
    Anatomy Department, St. Georges University of London, London, United Kingdom
  • Graham Thompson
    Vitreoretinal, Moorfields Eye Hospital, London, United Kingdom
  • Footnotes
    Commercial Relationships Louisa Wickham, None; Abdul-Kadir Karim, None; Mostafa Elgohary, None; Kam Ballagan, None; Raymond Moss, None; Maria Firth, None; Gary Firth, None; Graham Thompson, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1351. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Louisa Wickham, Abdul-Kadir Karim, Mostafa Elgohary, Kam Ballagan, Raymond Moss, Maria Firth, Gary Firth, Graham Thompson; A comparison of Water Soluble Antioxidants in Human Vitreous Humour in Retinal Ischaemia. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1351.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To estimate the levels of water soluble antioxidants, ascorbate and uric acid in patients with retinal ischaemia from samples taken at the time of vitrectomy.

Methods: 104 patients undergoing primary vitrectomy were recruited from a vitreoretinal clinic at the time of listing for surgery. Patients were classified according to whether retinal ischaemia was present. A blood sample was taken from patients just prior to the commencement of surgery. A dry core vitreous sample was then taken at the start of surgery. A full drug history, including vitamin supplementation was taken from all patients.

Results: Of the 45 patients classified as ischaemic, 38 were diabetic. In the non-ischaemic group (N = 59) the main indications for surgery were macular hole (N=33) and epiretinal membrane (N=14). The mean age at the time of surgery was 68 years (interquartile range (IQR) 63 - 77) in the non-ischaemic group and 59 years (IQR 49-69) in the ischaemic group. Levels of ascorbate were significantly reduced in the vitreous (p<0.001) and plasma (p<0.001) of patients with retinal ischaemia. There was no significant difference in the number of patients taking vitamin supplements containing ascorbate between the 2 groups (Χ2= 1.2, p=0.265). Vitreous (p<0.001) and plasma (p=0.04) levels of uric acid were significantly increased in patients with retinal ischaemia.

Conclusions: Vitreous levels of ascorbate are decreased in patients with retinal ischaemia and this may reflect it’s antioxidant role in these patients. It is likely that plasma levels of ascorbate are similarly reduced due to mobilisation by active transport across the concentration gradient into the vitreous. Uric acid levels have been reported to be higher in patients with retinal ischaemia, a finding that was repeated in this study.

Keywords: 763 vitreous • 499 diabetic retinopathy • 572 ischemia  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×